Optimization of humanized IgGs in glycoengineered Pichia pastoris.
about
Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cellsEngineering of routes to heparin and related polysaccharidesGlycotherapy: new advances inspire a reemergence of glycans in medicineImmune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesA phenylalanine to serine substitution within an O-protein mannosyltransferase led to strong resistance to PMT-inhibitors in Pichia pastorisA dual-mode surface display system for the maturation and production of monoclonal antibodies in glyco-engineered Pichia pastorisEnhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant.Modern Technologies for Creating Synthetic Antibodies for Clinical application.Expression, intracellular targeting and purification of HIV Nef variants in tobacco cells.N-glycan modification in Aspergillus species.Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response.Dynamic fluctuations of protein-carbohydrate interactions promote protein aggregation.Glycosylation of therapeutic proteins: an effective strategy to optimize efficacyFc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent CytotoxicityA visual method for direct selection of high-producing Pichia pastoris clonesCell culture processes for monoclonal antibody production.Plant glyco-biotechnology on the way to synthetic biologyProduction of biopharmaceutical proteins by yeast: advances through metabolic engineering.Generation of diploid Pichia pastoris strains by mating and their application for recombinant protein production.IgG subclasses and allotypes: from structure to effector functions.Fed-batch fermentation of GM-CSF-producing glycoengineered Pichia pastoris under controlled specific growth rate.Humanization of yeast to produce complex terminally sialylated glycoproteins.Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newbornRapid Fc glycosylation analysis of Fc fusions with IdeS and liquid chromatography mass spectrometryIntramolecular N-glycan/polypeptide interactions observed at multiple N-glycan remodeling steps through [(13)C,(15)N]-N-acetylglucosamine labeling of immunoglobulin G1.Enhanced production of recombinant secretory proteins in Pichia pastoris by optimizing Kex2 P1' site.In vitro enzymatic treatment to remove O-linked mannose from intact glycoproteins.EB66 cell line, a duck embryonic stem cell-derived substrate for the industrial production of therapeutic monoclonal antibodies with enhanced ADCC activity.Chemoenzymatic synthesis and Fcγ receptor binding of homogeneous glycoforms of antibody Fc domain. Presence of a bisecting sugar moiety enhances the affinity of Fc to FcγIIIa receptor.Evaluating interaction forces between BSA and rabbit anti-BSA in sulphathiazole sodium, tylosin and levofloxacin solution by AFM.Emerging technologies for making glycan-defined glycoproteinsGlycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities.Analysis of the N-glycans of recombinant human Factor IX purified from transgenic pig milkLepidopteran cells, an alternative for the production of recombinant antibodies?Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions.Production, characterization, and pharmacokinetic properties of antibodies with N-linked mannose-5 glycans.Efficient antibody production upon suppression of O mannosylation in the yeast Ogataea minutaPost-translational modifications in the context of therapeutic proteins.High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension.Regulation of methanol utilisation pathway genes in yeasts
P2860
Q26852287-5A2AA377-3F5C-4266-8C3C-CA7621FC99FBQ27013519-2FC2E377-B999-4AD7-A60C-EFDB25B7DB86Q27027997-BAA45DDF-2861-429D-B81E-812B235C152DQ28069362-650D5C2B-15E0-4FB8-9710-283FD81E75D2Q28487786-9799FBB0-3456-4D79-8051-6AFDBF555781Q28534600-F0DFE0CE-154D-429A-A3D7-9E188114403AQ30224854-C6881DA6-EBE7-4F55-BAC7-FF90AEBF832EQ30467308-2ECABF30-63A0-4E36-AF49-AD296E5C31C7Q33275586-E7BF49CC-71DE-4E78-A324-799958B63C82Q33310581-BD9BBEAF-BA2D-4C38-ABC9-3D01C47BC28EQ33325527-E972AAB8-A7E0-4A81-BEA9-1718FBC4A93BQ33520919-3AC57713-F6AA-4AE6-9747-20AA67AC75E9Q33586660-F46F1DB7-9D32-4FAB-BCEE-BA20EFAB677DQ33766365-7ADC3F57-2533-42BF-BF9A-C5E4F912EF7DQ33850334-3F448AEB-75E8-420D-B43B-DEEEA5C01B71Q34125491-762A5D0D-C890-49FC-B033-A7DBBCEACE1DQ34304795-C6E673CA-E2D0-4945-8162-250256A14819Q34311347-8E046A5D-F4B3-479B-9156-E0ED9237070CQ34322730-B854E78B-8468-4CAA-9B72-8ECA78E56435Q34368678-A929E5E1-8D73-4DEE-AD31-3B2A0A9FC1DDQ34419137-AD44004B-A92F-469A-86E3-97823115E273Q34564538-33792FAE-73AB-4C11-BC4B-412FBC37DA1CQ34803358-C5C9D998-7C4D-47EA-9F97-D6160EF42AA4Q34803946-3628FB15-8135-4259-9B19-7369EA648CB6Q34999126-5D6F7C5B-7E64-442A-B94E-CC4D54388240Q34999563-C7F92339-6A10-4E77-9EAB-FE01D1C23B22Q35094113-A0D1105A-0A76-41DD-9659-9F8661F386B7Q35232342-4008F789-3007-49B5-835C-F4FCDBB71DE2Q35555990-A0AE7F7A-64DC-48AF-A8F5-D5CA5C4E80F1Q35632395-1A876918-284F-4738-A7A0-3150984459CFQ35685635-5E9CACAD-39F5-4DDA-BB89-F042CB2C62E9Q35705039-F5591B64-DEA8-4D4D-B53B-7F8E53E25865Q35835707-E79A9EDD-ADD5-4C01-AB23-3547BB2A4AB0Q35969904-4AFD2C2C-B30C-4B60-8944-DA834C559ECDQ36189447-8CB46F5A-B040-4C8B-942F-FE9673EE056FQ36402805-09546F2B-BC0E-4C91-8643-62B0CACA61C2Q36420948-D442FFF0-4BAF-45FA-A361-96101DD4EE15Q36620451-38CD08D8-5BCB-46C4-A32D-FD95F8937C58Q36659566-0F7D6561-4134-4C39-9CB4-320A3B3A6356Q36684082-60A799CD-4FE0-4DB4-80BE-CB0699FC1B7E
P2860
Optimization of humanized IgGs in glycoengineered Pichia pastoris.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Optimization of humanized IgGs in glycoengineered Pichia pastoris.
@en
Optimization of humanized IgGs in glycoengineered Pichia pastoris.
@nl
type
label
Optimization of humanized IgGs in glycoengineered Pichia pastoris.
@en
Optimization of humanized IgGs in glycoengineered Pichia pastoris.
@nl
prefLabel
Optimization of humanized IgGs in glycoengineered Pichia pastoris.
@en
Optimization of humanized IgGs in glycoengineered Pichia pastoris.
@nl
P2093
P2860
P356
P1433
P1476
Optimization of humanized IgGs in glycoengineered Pichia pastoris
@en
P2093
Bianka Prinz
Byung-Kwon Choi
Dongxing Zha
Huijuan Li
Jack P Hoopes
Juergen H Nett
Natarajan Sethuraman
Nga Rewa Houston-Cummings
P2860
P2888
P304
P356
10.1038/NBT1178
P577
2006-01-22T00:00:00Z